Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G ROSENBLUM

Showing results (161-170 of 243) with videos related to

Pageof 25
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumorsLiesbeth M Veenendaal, Hangqing Jin, Sophia Ran, et al.
Oncotarget|May 24, 2015
Photochemical activation of MH3-B1/rGel: a HER2-targeted treatment approach for ovarian cancerBente Bull-Hansen, Maria B Berstad, Kristian Berg, et al.
Cancer|July 13, 2002
Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanomaOmar Eton, Michael G Rosenblum, Sewa S Legha, et al.
Cancer|November 7, 2000
Cadherin expression in glandular tumors of the cervixA C Han, M I Edelson, A Peralta Soler, et al.
Molecular Pharmaceutics|February 2, 2011
Multiplexed PET probes for imaging breast cancer early response to VEGF₁₂₁/rGel treatmentMin Yang, Haokao Gao, Xilin Sun, et al.
Cancer Research|January 1, 1984
Clinical pharmacology of 99mTc-labeled liposomes in patients with cancerG Lopez-Berestein, L Kasi, M G Rosenblum, et al.
Gynecologic Oncology|September 12, 2020
Stereotactic body radiation therapy for oligometastatic gynecologic malignancies: A systematic reviewNikhil Yegya-Raman, Connie D Cao, Lara Hathout, et al.
Frontiers in Oncology|September 14, 2018
Metformin as a Therapeutic Target in Endometrial CancersTeresa Y Lee, Ubaldo E Martinez-Outschoorn, Russell J Schilder, et al.
Journal for Immunotherapy of Cancer|September 22, 2020
Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme BAna Alvarez de Cienfuegos, Lawrence H Cheung, Khalid A Mohamedali, et al.
Molecular Cancer Therapeutics|April 17, 2008
Antitumor activity of fibroblast growth factor receptor 3-specific immunotoxins in a xenograft mouse model of bladder carcinoma is mediated by apoptosisJorge L Martínez-Torrecuadrada, Lawrence H Cheung, Paula López-Serra, et al.
Pageof 25

Showing results (161-170 of 243) with videos related to

Sort By:
Pageof 25
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumorsLiesbeth M Veenendaal, Hangqing Jin, Sophia Ran, et al.
Oncotarget|May 24, 2015
Photochemical activation of MH3-B1/rGel: a HER2-targeted treatment approach for ovarian cancerBente Bull-Hansen, Maria B Berstad, Kristian Berg, et al.
Cancer|July 13, 2002
Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanomaOmar Eton, Michael G Rosenblum, Sewa S Legha, et al.
Cancer|November 7, 2000
Cadherin expression in glandular tumors of the cervixA C Han, M I Edelson, A Peralta Soler, et al.
Molecular Pharmaceutics|February 2, 2011
Multiplexed PET probes for imaging breast cancer early response to VEGF₁₂₁/rGel treatmentMin Yang, Haokao Gao, Xilin Sun, et al.
Cancer Research|January 1, 1984
Clinical pharmacology of 99mTc-labeled liposomes in patients with cancerG Lopez-Berestein, L Kasi, M G Rosenblum, et al.
Gynecologic Oncology|September 12, 2020
Stereotactic body radiation therapy for oligometastatic gynecologic malignancies: A systematic reviewNikhil Yegya-Raman, Connie D Cao, Lara Hathout, et al.
Frontiers in Oncology|September 14, 2018
Metformin as a Therapeutic Target in Endometrial CancersTeresa Y Lee, Ubaldo E Martinez-Outschoorn, Russell J Schilder, et al.
Journal for Immunotherapy of Cancer|September 22, 2020
Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme BAna Alvarez de Cienfuegos, Lawrence H Cheung, Khalid A Mohamedali, et al.
Molecular Cancer Therapeutics|April 17, 2008
Antitumor activity of fibroblast growth factor receptor 3-specific immunotoxins in a xenograft mouse model of bladder carcinoma is mediated by apoptosisJorge L Martínez-Torrecuadrada, Lawrence H Cheung, Paula López-Serra, et al.
Pageof 25